https://economictimes.indiatimes.com/markets/ipos/fpos/mankind-pharma-ipo-subscribed-15-32-times/articleshow/99828625.cms
0
0
4/28/23 at 12:25am
Organization
The Times of India
Author
ET Bureau
53 words
0
Comments
This will be one of the largest public issues by a domestic drug manufacturer after the ₹6,480-crore IPO of Gland Pharma in 2020. The qualified institutional buyers (QIB) category was subscribed 49 times, while the non-institutional investors or high net-wort…
You are the first to view
Create an account
or login to join the discussion